Regenerex Pharma (RGPX) Short term Debt (2017 - 2023)

Regenerex Pharma (RGPX) has 7 years of Short term Debt data on file, last reported at $131887.0 in Q1 2023.

• Quarterly Short term Debt changed 0.15% year-over-year to $131887.0 in Q1 2023, while the trailing twelve-month figure through Mar 2023 was $131887.0 (changed 0.15% YoY) and the FY2023 annual result came in at $131887.0, changed 0.15% from the prior year.
• Short term Debt was little changed at $131887.0 in Q1 2023 per RGPX's latest filing, from $131887.0 in the prior quarter.
• Across five years, Short term Debt topped out at $139287.0 in Q3 2022 and bottomed at $100.0 in Q4 2021.
• The 5-year median for Short term Debt is $130992.0 (2019), against an average of $123534.6.
• The widest annual swing landed in 2020, when Short term Debt changed 0.0%; it then surged 131787.0% in 2022.
• Tracing RGPX's Short term Debt over 5 years: stood at $130992.0 in 2019, then changed by 0.0% to $130992.0 in 2020, then slumped by 99.92% to $100.0 in 2021, then surged by 131787.0% to $131887.0 in 2022, then changed by 0.0% to $131887.0 in 2023.
• Per Business Quant, the three latest RGPX Short term Debt figures stand at $131887.0 (Q1 2023), $131887.0 (Q4 2022), and $139287.0 (Q3 2022).

Peer Comparison